ERS Publications Podcasts: Recent Episodes
ERS Publications Podcasts
Our ERS Publications podcasts feature: a monthly podcast from the European Respiratory Journal, which summarises the research findings of a number of papers published in each issue; podcasts from our book series, the ERS Monograph, with each relating to current book's topic of focus.
The latest ERS Monograph podcast focuses on an area that is evolving into a cornerstone of respiratory practice: thoracic ultrasound. Guido Marchi (Monograph Early Career Member representative) talks to Guest Editors of the Thoracic Ultrasound Monograph, Vineeth George and Christian B. Laursen. Their discussion covers key milestones and advances in the field, effective training, maintaining skills, research priorities and future opportunities. It is a conversation and, indeed, a book that truly reflects a challenging and inspiring research agenda.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Melanie Königshoff (Center for Lung Aging and Regeneration, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, and Geriatric Research Education and Clinical Center at the VA Pittsburgh Healthcare System, Pittsburgh, PA, USA) about her Back to Basics review of the hallmarks of the ageing lung, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025).Cite this podcast as: ERJ Podcast June 2026: The ageing lung. Eur Respir J 2026; 67: 26E6706 [https://doi.org/10.1183/13993003.E6706-2026].
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews John Fahy (Division of Pulmonary and Critical Care Medicine, and the Cardiovascular Research Institute, University of California, San Francisco,San Francisco, CA, USA) about his state-of-the-art review of the pathobiology and treatment of mucus plugs in asthma and COPD , published in this issue of the ERJ (https://doi.org/10.1183/13993003.02358-2025).Cite this podcast as: ERJ Podcast May 2026: Mucus plugs in asthma and COPD. Eur Respir J 2026; 67: 26E6705 [https://doi.org/10.1183/13993003.E6705-2026].
Key leaders of EMBARC (the European Multicentre Audit and Research Collaboration) Amelia Shoemark and Stefano Aliberti join Guido Marchi in a podcast focusing on the latest ERS Monograph: Bronchiectasis. Guido, who is the Early Career Member representative for the Monograph, asks Stefano and Amelia about the foundation of EMBARC and its increasing international reach, better integration of the patient voice, the impact of the 2025 European Respiratory Society (ERS) bronchiectasis guidelines, and the turning point in treatment that dipeptidyl peptidase-1 (DPP-1) offers.
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Sanja Stanojevic about the joint statement from the Global Initiative for Chronic Obstructive Lung Disease and the Global Lung Function Initiative regarding the use of spirometry to define airflow obstruction and diagnose COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02574-2025).Cite this podcast as: ERJ Podcast April 2026: Use of spirometry to define airflow obstruction and diagnose COPD. Eur Respir J 2026; 67: 26E6704. [https://doi.org/10.1183/13993003.E6704-2026]
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Susanne Hansen (Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, and Centre for Clinical Research and Prevention, Frederiksberg Hospital, Copenhagen, Denmark) about her article on mortality in severe asthma as revealed by results from the NORDSTAR cohort, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02244-2025).Cite this podcast as: ERJ Podcast March 2026: Mortality in severe asthma. Eur Respir J 2026; 67: 26E6703 [https://doi.org/10.1183/13993003.E6703-2026].
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews David Halpin (University of Exeter Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK) about his Viewpoint editorial on a shared vision from the Global Initiative for Chronic Obstructive Lung Disease and the Global Initiative for Asthma of how to address the global challenges of COPD and asthma, published in this issue of the ERJ (https://doi.org/10.1183/13993003.02244-2025).Cite this podcast as: ERJ Podcast February 2026: Addressing the global challenges of COPD and asthma. Eur Respir J 2026; 67: 26E6702 [https://doi.org/10.1183/13993003.E6702-2026].
In this instalment of the ERS Monograph podcast, Guido Marchi (Early Career Member representative for the Monograph) meets with the Guest Editors of Chronic Cough: Woo-Jung Song, Lorcan McGarvey, Peter S.P. Cho and Kian Fan Chung. They reflect on the way in which chronic cough has evolved from being just a symptom of other diseases to an independent condition recognised for its complexity. In a lively and informative discussion, they cover topics such as antitussive development, the key tools and methods of chronic cough assessment, and the importance of a multidisciplinary team in the cough clinic.
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Janice Leung about the clinical, physiological, imaging and molecular responses to cannabis smoking seen in the Canadian Users of Cannabis Smoke study published in this issue of the ERJ (https://doi.org/10.1183/13993003.01659-2025).Cite this podcast as: ERJ Podcast January 2026: Cannabis and the lung. Eur Respir J 2026; 67: 26E6701 [https://doi.org/10.1183/13993003.E6701-2026].
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin for their end-of-year roundup of their highlights from the ERJ in 2025.Cite this podcast as: ERJ Podcast December 2025: Year in review. Eur Respir J 2025; 66: 25E6606. [doi.org/10.1183/13993003.E6606-2025]
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers, Deputy Chief Editor Don Sin and European Respiratory Review Chief Editor Rory Morty discuss the merits and pitfalls of the rapidly increasing use of generative AI in scientific publishing.Cite this podcast as: ERJ Podcast November 2025: Artificial intelligence in publishing. Eur Respir J 2025; 66: 25E6605. [doi.org/10.1183/13993003.E6605-2025]
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in her review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]
, which he co-Guest Edited with Athénaïs Boucly and Robin Condliffe. Gabor explains how the Monograph addresses diagnosis and can be used to guide the nonspecialist, highlights the importance of the multidisciplinary team, and brings important areas of future research into focus.
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Marcus Mall about neutrophil-derived biomarkers in bronchiectasis, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.00081-2025Cite this podcast as: ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis. Eur Respir J 2025; 55: 25E6603. [https://doi.org/10.1183/13993003.E6603-2025]
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Winfried Randerath (Bethanien Hospital, Clinic of Pneumology and Allergology, Centre for Sleep Medicine and Respiratory Care, Institute of Pneumology at the University of Cologne, Solingen, Germany) about the European Respiratory Society and European Sleep Research Society statement on the treatment of central sleep apnoea with adaptive servo-ventilation in this issue of the ERJ: https://doi.org/10.1183/13993003.00263-2025Cite this podcast as: ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation. Eur Respir J 2025; 66: 25E6602 [doi.org/10.1183/13993003.E6602-2025].
“We really need to celebrate the exciting times in asthma but also focus on the advocacy for improving outcomes in research and in clinical practice”Leading asthma experts David Jackson, Vanessa McDonald and Ian Pavord meet with Monograph Editorial Board member Dorina Esendagli to discuss their 500-page authoritative guide to the latest developments in the field. They discuss pathophysiology, treatable traits, biomarkers, comorbidities, the importance of the multidisciplinary team, and the personal experiences that gave them a genuine passion for helping asthma patients.
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Walter McNicholas (School of Medicine and the Conway Research Institute, University College Dublin, and Department of Respiratory and Sleep Medicine, St Vincent’s Hospital Group, Dublin, Ireland) about the challenges of implementing European national driving regulations for obstructive sleep apnoea, as discussed in Prof. McNicholas’ article in this issue of the ERJ: https://doi.org/10.1183/13993003.02484-2024Cite this podcast as: ERJ Podcast July 2025: Implementation of European national driving regulations for OSA. Eur Respir J 2025; 66: 25E6601 [https://doi.org/10.1183/13993003.E6601-2025].
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Peter Gibson about distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Bruno Crestani about a series of articles published in the June issue of the ERJ on mechanistic studies in interstitial lung disease: building translational bridges in IPF research.
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Fernanda Almeida about the CHOICE multicentre, open-label randomised clinical trial.
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Dave Singh about pre- and post-bronchodilator spirometry in COPD.
Leaders in the transplantation field and well-regarded ERS Officers, Michael Perch and Federica Meloni, join Dorina Esendagli in a podcast focusing on the latest Monograph: Lung Transplantation. Covering the formidable topics of immunosuppressive treatment and post-transplant care, it is clear that both the podcast and book are hugely relevant to the transplant specialist. However, Michael and Federica explain that the book is also aimed at specialists in other areas of pneumology, as well as general physicians from beyond the respiratory field. Broadening understanding about this challenging area is essential if we are to improve prognosis and widen donor availability.
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin for their end-of-year roundup of their highlights from the ERJ in 2024.
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Sanjay Chotirmall about articles published from in the current issue.
"There isn't, and it is unlikely there ever will be, a single approach to long COVID. It's very much about personalised medicine."James Chalmers steps away from the ERJ briefly to discuss the recent Monograph on "COVID-19: An Update", which he co-Guest Edited with Catia Cilloniz and Bin Cao. Dorina Esendagli (the Monograph's Early Career Member representative) talks to James about diagnostic tools, diversity in clinical presentation, approaches to treatment, vaccine boosters for new variants, the treatable traits concept and, importantly, the ongoing problem of long COVID.
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews associate editor Marius Hoeper and Kelly Chin (UT Southwestern Medical Center, Dallas, TX, USA) about articles published from the World Symposium on Pulmonary Hypertension.
"We need to recognise that having an adolescent-specific service will ultimately provide the foundations for lifelong healthcare"Alexandra M. Nanzer joins Dorina Esendagli (the Monograph's Early Career Member representative) to talk about her Monograph, "The Transition of Respiratory Care: from Child to Adult". Their awareness-raising discussion covers areas such as: ensuring continuity of care throughout transition; the challenges faced during the process; the requirements of the patient; and the areas on which future research and funding should focus.
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin interview section editor Marc Humbert and Pamela McShane (University of Texas, Tyler, TX, USA) about articles presented at the ERS Congress.
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marianne Baastrup Soendergaard (Department of Respiratory Medicine, Copenhagen University Hospital – Bispebjerg, Copenhagen, Denmark) about the OPTIMAL study: an open-label randomised controlled trial of titration of anti-interleukin-5 biologic therapy in severe asthma.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Rachel Bowsher (Toxicology Department, UK Health Security Agency, Chilton, and Pharmacology Section, St George’s University of London, London, UK) about a study that uses novel methodology to demonstrate that smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Steven D. Nathan (Inova Fairfax Hospital, Falls Church, VA, USA) about the PERFECT study, which showed that inhaled treprostinil does not demonstrate a positive risk–benefit ratio in favour of treatment in pulmonary hypertension associated with COPD.
"COPD is evolving. But we can manage it better and we should manage it better."Guest Editors Peter M.A. Calverley and James P. Allinson join Dorina Esendagli (Monograph Editorial Board member) to discuss their issue of the Monograph: COPD in the 21st Century. COPD is widely acknowledged as a leading cause of death and, in this podcast, Peter and James suggest that incidence and mortality may actually increase further, as understanding and diagnosis improve. They also look to the future, highlighting ways in which care can be enhanced through greater personalisation and removal of stigma.
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Steven Walker (Academic Respiratory Unit, Southmead Hospital, Bristol, UK) about the joint European Respiratory Society/European Association for Cardio-Thoracic Surgery/European Society of Thoracic Surgeons clinical practice guidelines on adults with spontaneous pneumothorax.
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Ritesh Agarwal (Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India) about the revised International Society for Human and Animal Mycology ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.
"Digital transformation is already happening. It's not a question of if, but how."The restrictions of the COVID-19 pandemic changed the landscape of digital healthcare forever. The respiratory field is at the forefront of this change, putting it in the exciting position of shaping the future use of digital care. In this podcast, Dorina Esendagli (from the ERS Monograph Editorial Board) talks to Guest Editors Vitalii Poberezhets and Hilary Pinnock about their issue of the Monograph, addressing the applications and safety of technology, the uses of big data and data protection, digital healthcare for patient self-management and remote supervision, and avoiding healthcare inequity.
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Joan Soriano about long COVID, which is the subject of a series of articles in the March and April issues of the ERJ.
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Nick Hopkinson about his study that shows consumption of nitrate-rich beetroot juice reduces cardiovascular risk factors in people living with COPD.
"We have to continue the investment in TB control and in TB research if we want to get rid of this long-standing foe of humanity"Guest Editors Alberto García-Basteiro and Füsun Öner Eyüboglu join Dorina Esendagli (the ERS Monograph's Early Career Representative) to discuss their Monograph: The Challenge of Tuberculosis in the 21st Century. In an in-depth conversation, they cover: key and updated areas in the book; the effect of the COVID-19 pandemic on TB global care; subclinical and latent TB infection; and new recommendations regarding treatment duration. Both Alberto and Füsun clearly demonstrate how, with continued investment and ongoing research, TB control can succeed.
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Early Career Editor Zhaozhong Zhu about the effects of the microbiome in early life on childhood asthma.
Breathe Chief Editor Brian Kent discusses the ERS International Congress 2023 with ERS early career members Joana Cruz, Sarah Alami and Siyu Dai.
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and Deputy Chief Editor Don Sin discuss their favourite articles from the past year and what they are looking forward to in 2024.
"There's always someone who knows more about a rare disease than you yourself"Coordinator of ERN-LUNG Thomas Wagner and his co-Guest Editor Michael Kreuter talk to Deputy Chief Editor of the ERS Monograph, Christian Laursen, about their issue: Rare Diseases of the Respiratory System. The editors explain how knowledge exchange through the Network, as well as reference to the Monograph, is beneficial to trainees, experts and patients alike. Christian also asks the Guest Editors about the major breakthroughs of the last 10 years, possible future developments, their recommendations to young researchers in the field, and the ways in which they support their patients in everyday practice.
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers and ERS President Monika Gappa discuss awareness of child health and its importance for adult lung health.
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin and Prof. Alberto Papi discuss the new ERS short guidelines for the use of as-needed ICS/formoterol in mild asthma.
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers, Deputy Chief Editor Don Sin, and Section Editors Isabella Annesi-Maesano and Joan Soriano talk about the Best of the ERJ session at the ERS International Congress 2023 and their favourite sessions from the rest of the Congress.
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Prof. Bartolome Celli about his editorial on simplifying pharmacotherapy for patients with COPD.
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Prof. Daiana Stolz about HISTORIC, a randomised, placebo-controlled, double-blind, investigator-initiated trial of airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor G.B. Migliori about the path to tuberculosis elimination.
"We need to be better at linking environmental health with human health"Ian Sinha and Jennifer Quint talk to ERS Monograph Editorial Board member Holly Keir about how the latest issue of the Monograph – Inequalities in Respiratory Health – can be used as a force for positive change. Their topical and thought-provoking discussion covers: ways in which clinicians can address inequality in their day-to-day practice; the best approach to data collection and pitfalls to avoid; the current and future impact of air quality; and the key challenges we face in health inequality and how to address them. As Ian says, "this Monograph gives people a resource that can help them make the changes they feel should happen."
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marcus Mall about the latest developments in cystic fibrosis.
As part of the April 2023 issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD)report.
"We need to be cognisant of the new, less common risk factors that are associated with various cancers"ERS Monograph early career representative Holly Keir talks to co-Guest Editor Kwun M. Fong about the Monograph on Lung Diseases and Cancer. In a conversation covering the bidirectional relationship between cancer and lung disease, the impact of climate change, cancer's relationship with vaping and the pulmonary effects of new cancer treatments, Kwun explains why this Monograph is relevant to all in respiratory medicine, from bench to bedside.
"This condition is really overlooked. The point of the Monograph is that it should, hopefully, raise awareness."
In the latest instalment of the ERS Monograph podcast series, Editorial Board member Holly Keir talks to James H. Hull, one of the Guest Editors of the Monograph on Complex Breathlessness. In a conversation that focuses on the need for robust investigation when faced with unexplained breathlessness, James and Holly discuss: the use of physiological tests and CPET for assessment; postural tachycardia syndrome and autonomic dysfunction; the importance of developing breathlessness clinics in the future; and therapy-based treatments, such as physiotherapy and speech and language therapy.
“One of the major motivations of this Monograph was to involve several specialities in order to provide the broadest overview of the manifestations of sarcoidosis”
In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Francesco Bonella and Daniel Culver, co-Guest Editors of the Monograph on Sarcoidosis. In an engaging conversation about this fascinating, chameleonic disease, Francesco and Daniel discuss multidisciplinary collaboration, advances of the last 10 years, areas of possible underdiagnosis and, importantly, the future. A conversation that really highlights how this Monograph is “an opportunity to grow the field.”
"A one-stop-shop for a better understanding of this important cell and all the diseases associated with it"
ERS Monograph early career representative Sheila Ramjug talks to David J. Jackson and Michael Wechsler about their Monograph, Eosinophilic Lung Diseases. In a conversation covering eosinophil types and the way they work, the safety of eosinophil depletion, key chapters and important questions for the future, David and Michael explain why this Monograph is relevant to everyone, both junior and senior physicians and scientists alike.
“Suddenly, I find myself involved in research and clinical care in a disease I hadn’t even heard about 2 ½ years ago”
In a conversation that really encapsulates the pandemic rollercoaster we continue to live through, Guest Editors Aurelie Fabre, John Hurst and Sheila Ramjug discuss the importance of the ERS Monograph on COVID-19, providing as it does a comprehensive review of all areas of the disease. This podcast is a fascinating listen for researchers and clinicians from both within and beyond respiratory medicine, and will even appeal to the lay listener. The podcast covers the incentives behind a COVID Monograph, standout chapters, the positives that can be drawn from the pandemic and the importance of collaboration: “a reflection of how much we can achieve when we work as one”.
"People's lives can be changed and [...] the important symptoms they are struggling with can be managed and in many cases, relieved"
In the latest instalment of the ERS Monograph podcast series, Editorial Board member Sheila Ramjug talks to Anne Holland, Professor of Physiotherapy at Monash University and Guest Editor of the Monograph on Pulmonary Rehabilitation. Their broad-ranging discussion covers everything from balancing a home life with a career in medicine, to the impact of COVID-19 on implementing pulmonary rehabilitation. Anne talks about the origins of pulmonary rehabilitation, the need to better personalise patient care, and recommends chapters that will help readers understand the patient experience and that provide practical tips on establishing a rehabilitation programme.
"In terms of preventing them coming to your clinic, the only thing we can do is focus on the early years."
The lasting impact of respiratory health in the early years, pre-birth and even pre-conception forms the focus of earnest and warm discussion in this latest fascinating Monograph podcast. Ian P. Sinha and Jayesh Mahendra Bhatt, Guest Editors of Respiratory Diseases of the Newborn Infant, talk to Sheila Ramjug about what attracted them to the field, the reasons behind the Monograph’s compilation and its importance to non-paediatric respiratory physicians, the impact of socioeconomic status on lung health and the devastating effects of child poverty.
Marko Nikolic and Brigid Hogan discuss the Monograph on Lung Stem Cells in Development, Health and Disease with Editorial Board member Sheila Ramjug. Featuring a fascinating and inspiring discussion about balancing a career as both a clinician and scientist, Sheila also asks the guest editors why this book is so important to both professions, which chapters they would recommend, new models in stem cell science and what the future holds.
Order your print copy of the book at ersbookshop.com or visit books.ersjournals.com to access the book online
ERS Monograph Editorial Board member Dr Sheila Ramjug interviews Guest Editors Dr Sofia Belo Ravara, Dr Paraskevi Katsaounou and Professor Keir Lewis about the latest ERS Monograph, Supporting Tobacco Cessation. In a discussion covering personal interests in the field and more controversial issues, such as e-cigarettes as a stop-smoking device, the Guest Editors demonstrate how this Monograph is not only an interesting read but has a practical application in the clinic.
In this podcast, Dr Sheila Ramjug (member of the ERS Monograph Editorial Board) interviews Guest Editor Dr Johanna Feary and contributing author Professor Mohamed Jeebhay about the latest ERS Monograph on Occupational and Environmental Lung Disease. In an interesting and thought-provoking discussion, Johanna and Mohamed share the reasons for their personal interest in the field, as well as their "must read" Monograph chapters. They also consider weighty issues, such as gender balance in the workplace and its effect, old and new agents causing disease and whether diagnosis of occupational lung disease is improving.
The latest ERS Monograph podcast focuses on the new issue: Cardiovascular Complications of Respiratory Disorders. Editorial Board member Dr Sheila Ramjug asks Guest Editor Professor Miguel Ángel Martínez-García about his career path, what drew him to cardiovascular complications, his experiences of joint working between cardiology and respiratory departments, and the key chapters in the Monograph.
As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor Martin Kolb interviews Kevin K. Brown (National Jewish Health, Denver, CO, USA) and Athol U. Wells (Royal Brompton Hospital, London, UK) about analyses of data from the INBUILD and INPULSIS trials suggesting that progressive fibrosing interstitial lung diseases other than idiopathic pulmonary fibrosis have a clinical course similar to IPF.
This second ERS Monograph podcast on pleural disease takes the form of a question and answer session. ERS Monograph Editorial Board member Dr Sheila Ramjug puts your questions to Professor Najib Rahman about the management of pneumothorax and trapped lung, empyema and the RAPID score, as well as AMPLE-2 in daily practice. You can download the Pleural Disease eBook at books.ersjournals.com (ERS members have free access).
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Peter G. Middleton (University of Sydney, Sydney, Australia) about the European Respiratory Society and the Thoracic Society of Australia and New Zealand’s new statment on the management of reproduction and pregnancy in women with airways diseases published in this issue.
ERS has recorded a special edition podcast to coincide with the forthcoming ERS Monograph on Pleural Disease. Editorial Board member Dr Sheila Ramjug asks how Guest Editors Professor Christian Laursen and Professor Najib Rahman began working in the field, and what the recent significant changes in both pleural disease and thoracic ultrasound have been. They also discuss the rationale behind the Monograph, the key chapters in the book and the upcoming ERS Courses in the area. Listen to the podcast here and visit ersbookshop.com to pre-order your copy of Pleural Disease.
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Alyn Morice (University of Hull, Hull, UK) about the European Respiratory Society’s new guidelines on the diagnosis and treatment of chronic cough in adults and children published in this issue.
Alyn Morice is Chief Editor of ERJ Open Research. Sign up for ERJ Open Research alerts at https://openres.ersjournals.com/alerts
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor Martin Kolb interviews Jørgen Vestbo (ERS Advocacy Council Chair) about the European Respiratory Society's position on tobacco harm reduction published in this issue.
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Sarah Hiles (University of Newcastle, Callaghan, Australia), Peter Gibson (University of Newcastle, Callaghan, and John Hunter Hospital, New Lambton Heights, Australia) and Guy Brusselle (Ghent University Hospital, Ghent, Belgium, and Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands) about their individual patient data meta-analysis of the use of azithromycin in severe asthma published in this issue.
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews Michael Loebinger (Royal Brompton Hospital and Imperial College London, UK) and Jakko van Ingen (Radboud University Medical Center, Nijmegen, the Netherlands) about five articles on the subject on nontuberculous mycobacteria published in this issue.
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor Martin Kolb interviews Toby Maher (Royal Brompton Hospital and Imperial College London, UK) about two articles in this issue reporting the results of randomised controlled trials in idiopathic pulmonary fibrosis.
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Section Editor Marc Humbert interviews Nazzareno Galiè (University of Bologna, Bologna, Italy) about a collection of articles in this issue arising from the Sixth World Symposium on Pulmonary Hypertension.
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor James Chalmers interviews David Lederer (Editor-in-Chief, Annals of the American Thoracic Society) about the outcome of a recent discussion among respiratory journal editors on the reporting of causal inference studies.
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Section Editor David Gozal interviews Walter McNicholas (St Vincent’s University Hospital and University College Dublin, Ireland) about a report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society.
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews Marc Humbert (Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, and AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, and INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France) about omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count.
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Andreas von Leupoldt (University of Leuven, Belgium) and Thomas Similowski (Sorbonne Universités and Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, France) about how observing dyspnoea in others elicits dyspnoea, negative affect and brain responses.
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. To mark World TB Day, chief editor Martin Kolb interviews section editor Giovanni Battista Migliori about the following articles.
Borisov SE, Dheda K, Enwerem M, et al. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J 2017; 49: 1700387.
Cabibbe AM, Sotgiu G, Izco S, et al. Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens. Eur Respir J 2017; 50: 1702292.
Falzon D, Schünemann HJ, Harausz E, et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 2017; 49: 1602308.
Guglielmetti L, Jaspard M, Le Dû D, et al. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J 2017; 49: 1601799.
Miotto P, Tessema B, Tagliani E, et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50: 1701354.
Pontali E, Sotgiu G, Tiberi S, et al. Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence. Eur Respir J 2017; 50: 1701462.
Van der Werf MJ, Hollo V, Ködmön C, et al. Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union. Eur Respir J 2017; 49: 1601992.
As part of the February issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Martin Kolb interviews Jørgen Vestbo (The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK) about the important difference between standard efficacy trials and real-world effectiveness trials such as the Salford Lung Study.
As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews the Anthony De Soyza (Newcastle University, Newcastle, UK) and Timothy Aksamit (Mayo Clinic, Rochester, MN, USA) about the RESPIRE1 and RESPIRE2 trials of ciprofloxacin in non-cystic fibrosis bronchiectasis. These two global phase III trials enrolled a total of 937 and test two dosing regimens tested (identical dose). The range of treatment estimates favours use of a ciprofloxacin dry powder inhaler (DPI), which was overall, well tolerated, with high compliance and an excellent safety profile. The ciprofloxacin DPI 14-day regimen gave a 144-day delay in the to time to first exacerbation and a 25% reduction in the frequency of exacerbations, and the 28-day regimen gave a 138-day delay in to time to first exacerbation and a 28% reduction in frequency of exacerbations.
As part of the December issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert interviews the incoming Chief Editor Martin Kolb and Deputy Chief Editor James Chalmers about the future of the ERJ, and reflects on his own time as Chief Editor.
As part of the November issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the ERS statement on the diagnosis and treatment of pulmonary disease caused by α1-antitrypsin deficiency with Task Force chairs Marc Miravitlles (Hospital Universitari Vall d’Hebron, Barcelona, Spain) and Robert A. Stockley (Queen Elizabeth Hospital, Birmingham, UK).
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the lessons learned from clinical trials in idiopathic pulmonary fibrosis over the past 25 years with Prof. Ganesh Raghu from the University of Washington, Seattle, WA, USA.
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a survey of patients with severe asthma with Prof. Helen K. Reddel from the University of Sydney, Sydney, and the NHMRC Centre for Research Excellence in Severe Asthma, Newcastle, Australia.
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief editor Marc Humbert discusses the publication of the results of a trial of fevipiprant, an oral prostaglandin in DP2 receptor (CRTh2) antagonist, in allergic asthma that is not controlled by low-dose inhaled corticosteroids with Prof. Eric D. Bateman from the University of Cape Town, South Africa.